These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 35219587)

  • 1. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
    Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
    Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer.
    Mu W; Zhou Z; Shao L; Wang Q; Feng W; Tang Y; He Y; Wang Y
    Front Oncol; 2023; 13():1257985. PubMed ID: 38023171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis.
    Igarashi K; Nishizawa H; Saiki Y; Matsumoto M
    J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis in Cancer Progression.
    Zhang R; Chen J; Wang S; Zhang W; Zheng Q; Cai R
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells.
    Oliveira T; Hermann E; Lin D; Chowanadisai W; Hull E; Montgomery M
    Redox Biol; 2021 Nov; 47():102149. PubMed ID: 34600336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
    Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
    Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
    Wang M; Li S; Wang Y; Cheng H; Su J; Li Q
    Toxicol Appl Pharmacol; 2020 Aug; 401():115110. PubMed ID: 32533954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer.
    Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W
    Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546
    [No Abstract]   [Full Text] [Related]  

  • 11. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
    Lee J; Roh JL
    Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-
    Zhou Y; Qian W; Li X; Wei W
    Oxid Med Cell Longev; 2023; 2023():7098313. PubMed ID: 36699318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Peroxidation, GSH Depletion, and
    Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
    DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 17. Broadening horizons: the role of ferroptosis in cancer.
    Chen X; Kang R; Kroemer G; Tang D
    Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
    Jinesh GG; Brohl AS
    Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
    Cho ES; Kang HE; Kim NH; Yook JI
    Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
    Kim H; Choi JA; Kim JH
    J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.